Built on Google Cloud and Gemini Enterprise Agent Platform, Graph Safety cuts pharmacovigilance costs by 66% with deterministic, inspection-ready AI. Graph Safety Suite helps safety teams scale ...

Graph AI, a California-based AI life sciences company specialising in patient safety and pharmacovigilance, has secured $3 million in a seed funding round led by Bessemer Venture Partners. Founded in ...

The company’s flagship product, Graph Safety, uses context-aware AI to automate the detection and reporting of adverse drug events (ADEs), a process traditionally handled by large teams of ...

Graph AI, a California-based artificial intelligence firm focused on drug safety and pharmacovigilance, has raised $3 million in seed funding led by Bessemer Venture Partners. The startup plans to use ...